Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;49(6):351-77.
doi: 10.2165/11319320-000000000-00000.

Multiple peaking phenomena in pharmacokinetic disposition

Affiliations
Review

Multiple peaking phenomena in pharmacokinetic disposition

Neal M Davies et al. Clin Pharmacokinet. 2010 Jun.

Abstract

Multiple peaking in the blood fluid concentration-time curve is a phenomenon occasionally encountered in pharmacokinetics. When it occurs, it can create difficulties in the determination and interpretation of pharmacokinetic parameters. Multiple peaking can occur as a consequence of a number of different mechanisms. These include, in addition to others, factors related to the formulation, be it the drug chemical entity itself or other formulation-related factors such as the excipients incorporated into the product design. Another contributing factor that can work in concert with the formulation is the physiological makeup of the gastrointestinal tract itself. This includes the pH and components of bile such as bile salts and phospholipids, the secretion of which is regulated by hormonal and dietary factors. In some cases, biochemical differences in the regional areas of the gastrointestinal tract, such as regio-specificity in bile concentrations and/or transport proteins, could contribute to windows for absorption that result in multiple peaking of xenobiotics. One of the most common sources of multiple peaking is contributed by biliary secretion followed by intestinal reabsorption of a drug, a process for which the term 'enterohepatic recycling' has been coined. This cause of multiple peaking is associated with special consideration in the calculation and interpretation of the drug clearance and volume of distribution. In this review, each of these various causes of multiple peaking is discussed, with incorporation of relevant examples for illustrative purposes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Drug Metab Pharmacokinet. 1985 Jan-Mar;10(1):61-9 - PubMed
    1. Biopharm Drug Dispos. 1996 Apr;17(3):249-58 - PubMed
    1. Antimicrob Agents Chemother. 2007 May;51(5):1822-6 - PubMed
    1. Drug Metab Dispos. 1990 Jul-Aug;18(4):471-5 - PubMed
    1. Cephalalgia. 1997 Jun;17(4):541-50 - PubMed

LinkOut - more resources